ABT
Abbott Laboratories
- Total liabilities, 2025
- $33.9B
- YoY, 2025
- +1.3%
- 5-year CAGR
- −3.0%
- 10-year CAGR
- +5.5%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $33.9B | +1.3% |
| 2024 | $33.5B | −2.5% |
| 2023 | $34.4B | −8.4% |
| 2022 | $37.5B | −4.2% |
| 2021 | $39.2B | −0.9% |
| 2020 | $39.5B | +8.1% |
| 2019 | $36.6B | +0.4% |
| 2018 | $36.5B | −19.3% |
| 2017 | $45.2B | +41.3% |
| 2016 | $31.9B | +60.4% |
| 2015 | $19.9B | +1.8% |
| 2014 | $19.6B | +10.6% |
| 2013 | $17.7B | −56.2% |
| 2012 | $40.4B | +13.1% |
| 2011 | $35.8B | −5.4% |
| 2010 | $37.8B | +28.6% |
| 2009 | $29.4B | +18.0% |
| 2008 | $24.9B | +13.8% |
| 2007 | $21.9B | — |